Cited by 240Cystic Fibrosis Research AdvancesBacterial biofilms and quorum sensingChronic Obstructive Pulmonary Disease (COPD) Research

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Changes in Cystic Fibrosis Airway Microbiota at Pulmonary Exacerbation

Open access

Carmody, Lisa A., Zhao, Jiangchao, Schloss, Patrick D., Petrosino, Joseph F., Murray, Susan, Young, Vincent B., Li, Jun Z., LiPuma, John J.·2013·Annals of the American Thoracic Society

DOI 10.1513/annalsats.201211-107ocPMC PMC3960905

Open this paper in CoChat — free account

Abstract

RATIONALE: In persons with cystic fibrosis (CF), repeated exacerbations of pulmonary symptoms are associated with a progressive decline in lung function. Changes in the airway microbiota around the time of exacerbations are not well understood. OBJECTIVES: To characterize changes in airway bacterial communities around the time of exacerbations and to identify predictors for these changes. METHODS: DNA prepared from 68 paired baseline and exacerbation sputum samples collected from 28 patients with CF were subjected to barcoded 16S rRNA gene pyrosequencing. Bacterial density was calculated by quantitative PCR. MEASUREMENTS AND MAIN RESULTS: Overall, significant differences in bacterial community diversity and bacterial density between baseline and exacerbation samples were not observed. However, considerable changes in community structures were observed in a subset of patients. In these patients, the dominant taxa and initial level of community diversity were significant predictors of the magnitude of community structure changes at exacerbation. Pseudomonas-dominant communities became more diverse at exacerbation compared with communities with other or no dominant species. The relative abundance of Gemella increased in 24 (83%) of 29 samples at exacerbation and was found to be the most discriminative genus between baseline and exacerbation samples. CONCLUSIONS: The magnitude of changes in the CF lung microbiota around the time of exacerbation was found to be largely dependent on community diversity and composition at baseline. Certain genera appear to play important roles in driving change in airway bacterial community composition at exacerbation. Gemella might play a direct role in and/or be a biomarker for pulmonary exacerbation.

Integrity signals

Registry

Crossref · 10.1513/annalsats.201211-107oc

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
A new method for non-parametric multivariate analysis of variance
Anderson, M. J. (2001) · Austral Ecology · doi:10.1111/j.1442-9993.2001.01070.pp.x · Cited by 13,828
An Ordination of the Upland Forest Communities of Southern Wisconsin
Bray, J. R., & Curtis, J. T. (1957) · Ecological Monographs · doi:10.2307/1942268 · Cited by 11,736
Reducing the Effects of PCR Amplification and Sequencing Artifacts on 16S rRNA-Based Studies
Schloss, P. D., Gevers, D., & Westcott, S. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027310 · Cited by 2,112
Self-citation
Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set
Nadkarni, M. A., Martin, F. E., Jacques, N. A., & Hunter, N. (2002) · Microbiology · doi:10.1099/00221287-148-1-257 · Cited by 1,931
The keystone-pathogen hypothesis
Hajishengallis, G., Darveau, R. P., & Curtis, M. A. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2873 · Cited by 1,790
Low-Abundance Biofilm Species Orchestrates Inflammatory Periodontal Disease through the Commensal Microbiota and Complement
Hajishengallis, G., Liang, S., Payne, M. A., Hashim, A., Jotwani, R., Eskan, M. A., McIntosh, M. L., Alsam, A., Kirkwood, K. L., Lambris, J. D., et al. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.10.006 · Cited by 1,154
Nonparametric estimation of Shannon’s index of diversity when there are unseen species in sample
Chao, A., & Shen, T. (2003) · Environmental and Ecological Statistics · doi:10.1023/a:1026096204727 · Cited by 810
Predictive 5-year survivorship model of cystic fibrosis
Liou, T. G., Adler, F. R., FitzSimmons, S. C., Cahill, B. C., Hibbs, J. R., & Marshall, B. C. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.4.345 · Cited by 749
Decade-long bacterial community dynamics in cystic fibrosis airways
Zhao, J., Schloss, P. D., Kalikin, L. M., Carmody, L. A., Foster, B. K., Petrosino, J. F., Cavalcoli, J. D., VanDevanter, D. R., Murray, S., Li, J. Z., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120577109 · Cited by 599
Self-citation

Show all 34 references

Research works printed but not linked: 1

Liaw, 2002, Classification and regression by randomforest, R News, 2, 18

Sorted by citations

Items 101–200 of 240

Profiling of Bacterial and Fungal Microbial Communities in Cystic Fibrosis Sputum Using RNA
Grahl, N., Dolben, E. L., Filkins, L., Crocker, A. W., Willger, S. D., Morrison, H. G., Sogin, M. L., Ashare, A., Gifford, A. H., Jacobs, N. J., et al. (2018) · mSphere · doi:10.1128/msphere.00292-18 · Cited by 25
Cystic Fibrosis Patients Infected With Epidemic Pseudomonas aeruginosa Strains Have Unique Microbial Communities
Acosta, N., Waddell, B. J. M., Heirali, A., Somayaji, R., Surette, M. G., Workentine, M. L., Rabin, H. R., & Parkins, M. D. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00173 · Cited by 26
Microbial community organization designates distinct pulmonary exacerbation types and predicts treatment outcome in cystic fibrosis
Stefanie Widder, A., Carmody, L. A., Opron, K., Kalikin, L. M., Caverly, L. J., & LiPuma, J. J. (2024) · Nature Communications · doi:10.1038/s41467-024-49150-y · Cited by 24
The Lung Microbiome in Young Children with Cystic Fibrosis: A Prospective Cohort Study
Linnane, B. M., Walsh, A. M., Walsh, C. J., Crispie, F., O’Sullivan, Ó., Cotter, P. D., McDermott, M., Renwick, J. A. A., & McNally, P. (2021) · Microorganisms · doi:10.3390/microorganisms9030492 · Cited by 25
Development of the respiratory tract microbiota in cystic fibrosis
de Koff, E. M., Groot, K. M. D. W., & Bogaert, D. (2016) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000316 · Cited by 26
Preliminary method for profiling volatile organic compounds in breath that correlate with pulmonary function and other clinical traits of subjects diagnosed with cystic fibrosis: a pilot study
Woollam, M. D., Siegel, A. P., Grocki, P., Saunders, J. L., Sanders, D. B., Agarwal, M., & Davis, M. D. (2022) · Journal of Breath Research · doi:10.1088/1752-7163/ac522f · Cited by 24
Lung Microbiome in Cystic Fibrosis
Scialò, F., Amato, F., Cernera, G., Gelzo, M., Zarrilli, F., Comegna, M., Pastore, L., Bianco, A., & Castaldo, G. (2021) · Life · doi:10.3390/life11020094 · Cited by 28
Strain-Resolved Dynamics of the Lung Microbiome in Patients with Cystic Fibrosis
Dmitrijeva, M., Kahlert, C. R., Feigelman, R., Kleiner, R. L., Nolte, O., Albrich, W. C., Baty, F., & von Mering, C. (2021) · mBio · doi:10.1128/mbio.02863-20 · Cited by 22
A Continuous-Flow Model for in vitro Cultivation of Mixed Microbial Populations Associated With Cystic Fibrosis Airway Infections
O’Brien, T. J., & Welch, M. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02713 · Cited by 21
Changes in microbiome diversity following beta-lactam antibiotic treatment are associated with therapeutic versus subtherapeutic antibiotic exposure in cystic fibrosis
Hahn, A., Fanous, H., Jensen, C. D., Chaney, H. R., Sami, I. R., Pérez, G. F., Koumbourlis, A. C., Louie, S. G., Bost, J. E., van den Anker, J. N., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-38984-y · Cited by 22
Recent advances in the understanding and management of cystic fibrosis pulmonary exacerbations
Skolnik, K., & Quon, B. S. (2018) · F1000Research · doi:10.12688/f1000research.13926.1 · Cited by 20
Altered community compositions of Proteobacteria in adults with bronchiectasis
Guan, W., Yuan, J.-J., Li, H., Gao, Y., Chen, C.-L., Huang, Y., Chen, R., & Zhong, N. (2018) · International Journal of COPD · doi:10.2147/copd.s159335 · Cited by 20
Citizen-science based study of the oral microbiome in Cystic fibrosis and matched controls reveals major differences in diversity and abundance of bacterial and fungal species
Willis, J. R., Saus, E., Iraola‐Guzmán, S., Cabello-Yeves, E., Księżopolska, E., Cozzuto, L., Bejarano, L. A., Andreu, N., Alloza-Trabado, M., Blanco, A., et al. (2021) · Journal of Oral Microbiology · doi:10.1080/20002297.2021.1897328 · Cited by 19
Lung Microbiome in Human Health and Diseases
Chauhan, N. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00077-2 · Cited by 20
Update on the diagnosis and management of cystic fibrosis pulmonary exacerbations
Cogen, J. D., & Quon, B. S. (2024) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2024.04.004 · Cited by 22
Azithromycin and the microbiota of cystic fibrosis sputum
Acosta, N., Thornton, C. S., Surette, M. G., Somayaji, R., Rossi, L., Rabin, H. R., & Parkins, M. D. (2021) · BMC Microbiology · doi:10.1186/s12866-021-02159-5 · Cited by 19
Airway microbiota and immune mediator relationships differ in obesity and asthma
Kozik, A. J., Begley, L., Lugogo, N. L., Baptist, A. P., Erb‐Downward, J. R., Opron, K., & Huang, Y. J. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.11.024 · Cited by 22
Pseudomonas aeruginosa Modulates the Antiviral Response of Bronchial Epithelial Cells
Sørensen, M. A., Kantorek, J., Byrnes, L., Boutin, S., Mall, M. A., Lasitschka, F., Zabeck, H., Nguyen, D. M., & Dalpke, A. H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00096 · Cited by 19
The Respiratory Microbiome in Cystic Fibrosis: Compartment Patterns and Clinical Relationships in Early Stage Disease
García-Núñez, M., González, M. G., Pomares, X., Montón, C., Millares, L., Quero, S., Prina, E., la Cruz, O. A.-D., García, M. B., Capilla, S., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01463 · Cited by 18
Inflammation in children with cystic fibrosis: contribution of bacterial production of long-chain fatty acids
Felton, E., Burrell, A., Chaney, H. R., Sami, I. R., Koumbourlis, A. C., Freishtat, R. J., Crandall, K. A., & Hahn, A. (2021) · Pediatric Research · doi:10.1038/s41390-021-01419-4 · Cited by 18
Discriminating typical and atypical cystic fibrosis‐related bacteria by multiplex PNA‐FISH
Lopes, S. P., Carvalho, D. T. O., Pereira, M. O., & Azevedo, N. F. (2016) · Biotechnology and Bioengineering · doi:10.1002/bit.26085 · Cited by 18
Recapitulation of Polymicrobial Communities Associated with Cystic Fibrosis Airway Infections: A Perspective
O’Brien, T. J., & Welch, M. (2019) · Future Microbiology · doi:10.2217/fmb-2019-0200 · Cited by 16
Microbiome Data Enhances Predictive Models of Lung Function in People With Cystic Fibrosis
Zhao, C., Hao, Y., Wang, Y., Varga, J. J., Stecenko, A. A., Goldberg, J. B., & Brown, S. P. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa655 · Cited by 17
Single Treatment of Vitamin D3 Ameliorates LPS‐Induced Acute Lung Injury through Changing Lung Rodentibacter abundance
Jin, A., Zhao, Y., Yuan, Y., Ma, S., Chen, J., Yang, X., Lu, S., & Sun, Q. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202100952 · Cited by 15
Acute Pulmonary Exacerbation Phenotypes in Patients with Cystic Fibrosis
Carter, S. C., Franciosi, A. N., O’Shea, K. M., O’Carroll, O., Sharma, A. K., Bell, A., Keogan, B., O’Reilly, P., Coughlan, S., Law, S. M., et al. (2022) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202111-1266oc · Cited by 16
The metabolic footprint of the airway bacterial community in cystic fibrosis
Narayanamurthy, V., Sweetnam, J., Denner, D. R., Chen, L. W., Naureckas, E. T., Laxman, B., & White, S. R. (2017) · Microbiome · doi:10.1186/s40168-017-0289-z · Cited by 16
How can the cystic fibrosis respiratory microbiome influence our clinical decision-making?
Rogers, G. B., Bruce, K. D., & Hoffman, L. R. (2017) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000419 · Cited by 15
Systems Biology and Bile Acid Signalling in Microbiome-Host Interactions in the Cystic Fibrosis Lung
Woods, D. F., Flynn, S., Caparros-Martin, J. A., Stick, S. M., Reen, F. J., & O’Gara, F. (2021) · Antibiotics · doi:10.3390/antibiotics10070766 · Cited by 16
The Function and Molecular Mechanism of Commensal Microbiome in Promoting Malignant Progression of Lung Cancer
Wang, H., Hu, J., Wu, J., Ji, P., Shang, A., & Li, D. (2022) · Cancers · doi:10.3390/cancers14215394 · Cited by 14
Mucolytic bacteria: prevalence in various pathological diseases
Selwal, K. K., Selwal, M. K., & Yu, Z. (2021) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-021-03145-9 · Cited by 14
Deciphering Microbiota of Acute Upper Respiratory Infections: A Comparative Analysis of PCR and mNGS Methods for Lower Respiratory Trafficking Potential
Almas, S., Carpenter, R. E., Singh, A., Rowan, C., Tamrakar, V. K., & Sharma, R. (2023) · Advances in respiratory medicine · doi:10.3390/arm91010006 · Cited by 14
Integrating and Mining Diverse Data in Human Immunological Studies
Siebert, J., Wagner, B. D., & Juarez‐Colunga, E. (2014) · Bioanalysis · doi:10.4155/bio.13.309 · Cited by 13
Impact of storage conditions on metabolite profiles of sputum samples from persons with cystic fibrosis
Zhao, J., Evans, C. R., Carmody, L. A., & LiPuma, J. J. (2015) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2015.02.004 · Cited by 13
Clinically Promising Biomarkers in Cystic Fibrosis Pulmonary Exacerbations
Scott, L. K., & Toner, R. (2017) · Lung · doi:10.1007/s00408-017-0024-3 · Cited by 13
Microbiota: A Missing Link in The Pathogenesis of Chronic Lung Inflammatory Diseases
Magryś, A. (2021) · Polish Journal of Microbiology · doi:10.33073/pjm-2021-013 · Cited by 13
Lung Microbiota Changes Associated with Chronic Pseudomonas aeruginosa Lung Infection and the Impact of Intravenous Colistimethate Sodium
Collie, D., Glendinning, L., Govan, J. R. W., Wright, S. H., Thornton, E. M., Tennant, P. A., Doherty, C. J., & McLachlan, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142097 · Cited by 15
Respiratory Viruses and Cystic Fibrosis
Brackenborough, K., Ellis, H., & Flight, W. G. (2022) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0042-1758728 · Cited by 11
Expanding Our Understanding of Respiratory Microbiota in Cystic Fibrosis
LiPuma, J. J. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201407-303ed · Cited by 11
Dynamic Upper and Lower Airway Microbiotas in Paediatric Bronchiectasis Exacerbations: A Pilot Study
Broderick, D. T. J., Regtien, T., Ainsworth, A., Taylor, M. W., & Pillarisetti, N. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.773496 · Cited by 11
Using metabolic potential within the airway microbiome as predictors of clinical state in persons with cystic fibrosis
Shumyatsky, G., Burrell, A., Chaney, H. R., Sami, I. R., Koumbourlis, A. C., Freishtat, R. J., Crandall, K. A., Zemanick, E. T., & Hahn, A. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2022.1082125 · Cited by 10
Relationship between pediatric asthma and respiratory microbiota, intestinal microbiota: a narrative review
Liu, L., Zhao, W., Zhang, H., Shang, Y., Huang, W., & Cheng, Q. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1550783 · Cited by 13
Diminished airway host innate response in people with cystic fibrosis who experience frequent pulmonary exacerbations
Houston, C. J., Alkhatib, A., Einarsson, G. G., Tunney, M. M., Taggart, C. C., & Downey, D. G. (2023) · European Respiratory Journal · doi:10.1183/13993003.01228-2023 · Cited by 10
Episodic oral antibiotic use in CF: Discordance between the electronic medical record and self-report
Caverly, L. J., Caverly, T. J., Kalikin, L. M., Foster, B. K., Simon, R. H., & LiPuma, J. J. (2016) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2016.04.009 · Cited by 10
The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections
Comstock, W. J., Huh, E., Weekes, R., Watson, C., Xu, T., Dorrestein, P. C., & Quinn, R. A. (2017) · Journal of Visualized Experiments · doi:10.3791/55532 · Cited by 11
Metabonomics reveals altered metabolites related to inflammation and energy utilization at recovery of cystic fibrosis lung exacerbation
Muhlebach, M. S., Sha, W., MacIntosh, B., Kelley, T. J., & Muenzer, J. (2019) · Metabolism Open · doi:10.1016/j.metop.2019.100010 · Cited by 10
Cystic Fibrosis Mice Develop Spontaneous Chronic Bordetella Airway Infections
Darrah, R. J., Bonfield, T. L., LiPuma, J. J., Litman, P., Hodges, C. A., Jacono, F. J., & Drumm, M. L. (2017) · Journal of Infectious Pulmonary Diseases · doi:10.16966/2470-3176.128 · Cited by 10
What diagnostic tests are available for respiratory infections or pulmonary exacerbations in cystic fibrosis: A scoping literature review
Naseem, R., Howe, N., Williams, C. J., Pretorius, S., & Green, K. (2024) · Respiratory Investigation · doi:10.1016/j.resinv.2024.07.005 · Cited by 9
Strong incidence of Pseudomonas aeruginosa on bacterial rrs and ITS genetic structures of cystic fibrosis sputa
Pagès-Monteiro, L., Marti, R., Commun, C., Alliot, N., Bardel, C., Meugnier, H., de Montclos, M. P., Reix, P., Durieu, I., Durupt, S., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173022 · Cited by 12
Getting Our Fingers on the Pulse of Slow-Growing Bacteria in Hard-To-Reach Places
Gallagher, T. M., Phan, J. L., & Whiteson, K. (2018) · Journal of Bacteriology · doi:10.1128/jb.00540-18 · Cited by 9
The Airway Colonization by Opportunistic Filamentous Fungi in Patients with Cystic Fibrosis: Recent Updates
Touati, K., Nguyen, D. N. L., & Delhaès, L. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-014-0197-7 · Cited by 15
Outcomes of cystic fibrosis pulmonary exacerbations treated with antibiotics with activity against anaerobic bacteria
Castner, L. M., Zimbric, M., Cahalan, S. E., Powell, C. C., & Caverly, L. J. (2021) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2021.02.001 · Cited by 9
Analysis of airway microbiota in adults from a Brazilian cystic fibrosis center
Leite, C. C. F., de Freitas, F. A. D., Firmida, M. D. C., Leão, R. S., Albano, R. M., & Marques, E. A. (2020) · Brazilian Journal of Microbiology · doi:10.1007/s42770-020-00381-3 · Cited by 8
The lung microbiome
Rogers, G. B. (2017) · Emerging Topics in Life Sciences · doi:10.1042/etls20170043 · Cited by 8
The Elusive Role of Airway Infection in Cystic Fibrosis Exacerbation
Caverly, L. J., & VanDevanter, D. R. (2022) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piac062 · Cited by 9
Microbiota and mycobiota in bronchoalveolar lavage fluid of silicosis patients
Xie, L., Zhang, X., Gao, X., Wang, L., Cheng, Y., Zhang, S., Ji, Y., Tang, Y., Deng, Y., Zhang, B., et al. (2023) · Journal of Occupational Medicine and Toxicology · doi:10.1186/s12995-023-00377-3 · Cited by 8
Insights into the Adolescent Cystic Fibrosis Airway Microbiome Using Shotgun Metagenomics
McDermott, G., Walsh, A. M., Crispie, F., Frost, S., Greally, P., Cotter, P. D., O’Sullivan, Ó., & Renwick, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073893 · Cited by 7
The role of inflammation in cystic fibrosis pulmonary exacerbations
Houston, C. J., Taggart, C. C., & Downey, D. G. (2020) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2020.1778469 · Cited by 7
Airway bacterial community composition in persons with advanced cystic fibrosis lung disease
Thornton, C. S., Carmody, L. A., Kalikin, L. M., Opron, K., Caverly, L. J., & LiPuma, J. J. (2023) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2023.01.001 · Cited by 7
Benchmark Evaluation of True Single Molecular Sequencing to Determine Cystic Fibrosis Airway Microbiome Diversity
Hahn, A., Bendall, M. L., Gibson, K. M., Chaney, H. R., Sami, I. R., Pérez, G. F., Koumbourlis, A. C., McCaffrey, T. A., Freishtat, R. J., & Crandall, K. A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01069 · Cited by 7
The lower airway microbiome in paediatric health and chronic disease
Campbell, S., Gerasimidis, K., Milling, S. W. F., Dicker, A., Hansen, R., & Langley, R. (2024) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2024.02.001 · Cited by 8
The airway microbiota in siblings with primary ciliary dyskinesia: Related factors and correlation with clinical characteristics
Tural, D. A., Kaşıkçı, M., Polat, S. E., Özsezen, B., Hızal, M. G., Sunman, B., Büyükşahin, H. N., Güzelkaş, İ., Altay, Ö., Dolgun, T. Y., et al. (2023) · Pediatric Pulmonology · doi:10.1002/ppul.26816 · Cited by 6
Longitudinal changes in the cystic fibrosis airway microbiota with time and treatment
Einarsson, G. G., Sherrard, L. J., Hatch, J., Zorn, B., Johnston, E., McGettigan, C., O’Neill, K., Gilpin, D. F., Downey, D. G., Murray, M., et al. (2023) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2023.11.010 · Cited by 7
Changes in the lung bacteriome in relation to antipseudomonal therapy in children with cystic fibrosis
Kramná, L., Dřevı́nek, P., Lin, J., Kulich, M., & Cinek, O. (2017) · Folia Microbiologica · doi:10.1007/s12223-017-0562-3 · Cited by 6
Impact of Anaerobic Antibacterial Spectrum on Cystic Fibrosis Airway Microbiome Diversity and Pulmonary Function
Bozzella, M. J., Chaney, H. R., Sami, I. R., Koumbourlis, A. C., Bost, J. E., Zemanick, E. T., Freishtat, R. J., Crandall, K. A., & Hahn, A. (2021) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003211 · Cited by 6
Therapeutic interventions alter ecological interactions among cystic fibrosis airway microbiota
Ho, P.-M., Nazeer, R. R., & Welch, M. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1178131 · Cited by 6
Procalcitonin Predicts the Severity of Cystic Fibrosis Pulmonary Exacerbations and Readmissions in Adult Patients: A Prospective Cohort Study
Bailey, K. L., Murphy, P. J., Lineberry, O., Haack, M. R., Dickinson, J. D., & Kalil, A. C. (2020) · Journal of Investigative Medicine · doi:10.1136/jim-2019-001183 · Cited by 6
Airway Microbiome in Children with Cystic Fibrosis: A Review of Microbial Shifts and Therapeutic Impacts
Buruiană, G., Sima, C. M., Anton-Păduraru, D.-T., Bădescu, A. C., Luncă, C., Duhaniuc, A., & Dorneanu, O. (2025) · Medicina · doi:10.3390/medicina61091605 · Cited by 6
Lung microbiota changes during pulmonary Aspergillus fumigatus infection in rats
Popović, D., Kulaš, J. B., Tucović, D., Aleksandrov, A. P., Glamočlija, J., Bajić, S. S., Tolinački, M., Golić, N., & Mirkov, I. I. (2023) · Microbes and Infection · doi:10.1016/j.micinf.2023.105186 · Cited by 5
Chronic exposure to nanocellulose altered depression-related behaviors in mice on a western diet: The role of immune modulation and the gut microbiome
Xu, H. S., Chen, Y., Patel, A. R., Wang, Z., McDonough, C. M., & Guo, T. L. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122259 · Cited by 5
The presence of cystic fibrosis-related diabetes modifies the sputum microbiome in cystic fibrosis disease
Vasiljevs, S., Witney, A. A., & Baines, D. L. (2023) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00219.2023 · Cited by 5
Microbiology of the Cystic Fibrosis Airway
McDermott, G., Reece, E., & Renwick, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-809633-8.90263-2 · Cited by 6
Lower airway microbiota and decreasing lung function in young Brazilian cystic fibrosis patients with pulmonary Staphylococcus and Pseudomonas infection
Kussek, P. C., Mesa, D., Vasconcelos, T. M., Rodrigues, L. S., Krul, D., Ibañez, H. C., Faoro, H., Palmeiro, J. K., & Dalla-Costa, L. M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0273453 · Cited by 5
16S rRNA-Based Microbiota Profiling Assists Conventional Culture Analysis of Airway Samples from Pediatric Cystic Fibrosis Patients
Kristensen, M., de Koff, E. M., Chu, M. L. J. N., Groendijk, S., Tramper‐Stranders, G. A., Groot, K. M. D. W., Janssens, H. M., Tiddens, H. A. W. M., van Westreenen, M., Sanders, E. A. M., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.04057-22 · Cited by 5
Bacillus siamensis Improves the Immune Status and Intestinal Health of Weaned Piglets by Improving Their Intestinal Microbiota
Liu, H., Liu, X., Liu, H., Tang, J., He, W., Xu, T., Cheng, B., Shi, B., & Han, J. (2024) · Microorganisms · doi:10.3390/microorganisms12051012 · Cited by 5
Metabolism and Pathogenicity ofPseudomonas aeruginosaInfections in the Lungs of Individuals with Cystic Fibrosis
Palmer, G. C., & Whiteley, M. (2015) · ASM Press eBooks · doi:10.1128/9781555818883.ch9 · Cited by 5
Microbiome data enhances predictive models of lung function in people with cystic fibrosisPreprint
Zhao, C. Y., Hao, Y., Wang, Y., Varga, J. J., Stecenko, A. A., Goldberg, J. B., & Brown, S. P. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/656066 · Cited by 5
The Cystic Fibrosis Airway Microbiome and Pathogens
Janahi, I. A., & Rehman, A. (2017) · InTech eBooks · doi:10.5772/67846 · Cited by 3
Microbiome in Cystic Fibrosis
Caverly, L. J., Hoffman, L. R., & Zemanick, E. T. (2022) · Respiratory medicine · doi:10.1007/978-3-030-87104-8_6 · Cited by 4
Polymicrobial Biofilms in Cystic Fibrosis Lung Infections: Effects on Antimicrobial Susceptibility
Galdino, A. C. M., Vaillancourt, M., Celedonio, D., & Jorth, P. A. (2022) · Springer series on biofilms · doi:10.1007/978-3-031-15349-5_7 · Cited by 5
Microbiome in Chronic Lung Diseases
Mammen, M. J., & Sethi, S. (2017) · Barcelona Respiratory Network · doi:10.24875/brn.m17000010 · Cited by 4
Le microbiote pulmonaire
Ploton, M., Abakka, S., Amouyal, E., Besnard, C., Dufour, L., Harrif, S. E., Kipnis, C., Prim, B., Vignot, J. L., & Houdouin, V. (2017) · Archives de Pédiatrie · doi:10.1016/j.arcped.2017.04.007 · Cited by 6
Inflammation, age and changing microbiology: the search for causation in the cystic fibrosis airways
Rogers, G. B. (2017) · European Respiratory Journal · doi:10.1183/13993003.01935-2017 · Cited by 3
Discriminating between typical and atypical cystic fibrosis-related bacterial species by multiplex PNA-FISH
Lopes, S. P., Carvalho, D. T. O., Pereira, M. O., & Azevedo, N. F. (2017) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 3
Diversité physiopathologique du microbiote respiratoire
Michon, A.-L., & Marchandin, H. (2015) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(15)72820-0 · Cited by 5
Improvements in symptomatic treatment strategies for cystic fibrosis: delivering CF care in the 21st century
Addy, C., Downey, D. G., & Elborn, J. S. (2015) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2016.1107473 · Cited by 3
Pseudomonas aeruginosa and Bronchiectasis
Soyza, A. D., & Winstanley, C. (2017) · Springer eBooks · doi:10.1007/978-3-319-61452-6_12 · Cited by 3
Taxonomic variability over functional stability in the microbiome of Cystic Fibrosis patients chronically infected by Pseudomonas aeruginosaPreprint
Bacci, G., Taccetti, G., Dolce, D., Armanini, F., Segata, N., Cesare, F. D., Lucidi, V., Fiscarelli, E. V., Morelli, P., Casciaro, R., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/609057 · Cited by 3
Nontuberculous mycobacteria remodel lung microbiota in cystic fibrosis-associated respiratory infections
Hardman, M., Higgi, S. A. H., Hanson, L., Schutz, K. C., Wargo, M. J., Tenebäck, C. C., Daniels, T. W. V., Gast, C., & Rivett, D. W. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.00382-25 · Cited by 4
Lung microbiomes’ variable responses to dust exposure in mouse models of asthma
Maltz, M. R., Topacio, T. M., Lo, D. D., Zaza, M., Freund, L., Botthoff, J. K., Swenson, M. P., Cocker, D. R., Biddle, T. A., Yisrael, K., et al. (2025) · mSphere · doi:10.1128/msphere.00209-25 · Cited by 2
Hyphal growth determines spatial organization and coexistence in a pathogenic polymicrobial community in a spatially structured environment
Mancini, L., Saliekh, L., Claydon, R., Kotar, J., Bényei, É. B., Munro, C. A., Shendruk, T. N., Brown, A. T., Welch, M., & Cicuta, P. (2025) · The ISME Journal · doi:10.1093/ismejo/wraf279 · Cited by 3
Microbiology of the middle meatus compared to sputum in young patients with cystic fibrosis from Bahia – Brazil
Barros, A. T., Reis, J. N., Ramos, R. T. T., Santana, M. A., Diniz, A. L. N., Barros, T. F., Leal, A. K. S., Paixão, V. A., & Grassi, M. F. R. (2013) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2013.07.006 · Cited by 2
Daily variability of Pseudomonas aeruginosa density in cystic fibrosis sputum
Carmody, L. A., Caverly, L. J., Kalikin, L. M., Thornton, C. S., Simon, R. H., VanDevanter, D. R., & LiPuma, J. J. (2024) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2024.11.013 · Cited by 2
Exploring the role of microbiome in cystic fibrosis clinical outcomes through a mediation analysis
Koldaş, S. S., Sezerman, O. U., & Timuçin, E. (2025) · mSystems · doi:10.1128/msystems.00196-25 · Cited by 2
Assessing the Airway Microbiota in Cystic Fibrosis
Hoppe, J. E., Harris, J. K., & Zemanick, E. T. (2016) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2016.10.004 · Cited by 2
Microbiome in Chronic Lung Diseases
Mammen, M. J., & Sethi, S. (2017) · Barcelona Respiratory Network · doi:10.23866/brnrev:2017-m0042 · Cited by 5
Bacterial Infections and the Respiratory Microbiome
Waters, V. J., & LiPuma, J. J. (2020) · Respiratory medicine · doi:10.1007/978-3-030-42382-7_5 · Cited by 3
Bacterial infection
Provost, K. A., Frederick, C. A., & Sethi, S. (2017) · European Respiratory Society eBooks · doi:10.1183/2312508x.10016216 · Cited by 2
Artificial neural network‐based gene screening and immune cell infiltration analysis of osteosarcoma feature
Shi, S., Guo, Y., Wang, Q., & Huang, Y. (2023) · The Journal of Gene Medicine · doi:10.1002/jgm.3622 · Cited by 2
Bacterial Community Variability: Outliers May Be Leading Us Astray
Hahn, A., & Zemanick, E. T. (2019) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201909-716ed · Cited by 2
Comparison of Sputum and Oropharyngeal Microbiome Compositions in Patients with Non-Small Cell Lung Cancer
Baranova, E. D., Druzhinin, V. G., Matskova, L. V., Сергеевич, Д. П., Volobaev, V. P., & Викторович, Л. А. (2022) · OBM Genetics · doi:10.21926/obm.genet.2204169 · Cited by 1

Authors: Carmody, L. A., Zhao, J., Schloss, P. D., Petrosino, J. F., Murray, S., Young, V. B., Li, J. Z., & LiPuma, J. J.
Affiliations: University of Michigan (US)
Microbiology and Immunology
Baylor College of Medicine (US)
Departments of Pediatrics and Communicable Disease and
Corresponding author: LiPuma, John J.
ORCID: Carmody, Lisa A.
Zhao, Jiangchao
Schloss, Patrick D.
Petrosino, Joseph F.
Murray, Susan
Young, Vincent B.
Li, Jun Z.
LiPuma, John J.
Venue: Annals of the American Thoracic Society
Publisher: Oxford University Press (OUP)
Published: 2013-06-01
Volume: 10
Issue: 3
Pages: 179-187
ISSN: 2325-6621 (ISSN-L)
2329-6933
DOI: 10.1513/annalsats.201211-107oc
PMC: PMC3960905
OpenAlex: W2129800212
Cited by: 239
References: 34
Citations by year: 2026: 4 · 2025: 10 · 2024: 12 · 2023: 19 · 2022: 19 · 2021: 19 · 2020: 23 · 2019: 22 · 2018: 18 · 2017: 28 · 2016: 17 · 2015: 30 · 2014: 15 · 2013: 3
FWCI: 17.61
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: academic.oup.com/pages/standard-publication-reuse-rights (vor)
Locations: Annals of the American Thoracic Society (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Cystic Fibrosis Foundation
Georgia Clinical and Translational Science Alliance
National Institutes of Health (5rc1hl100809-02)
National Heart, Lung, and Blood Institute (U01HL098961, RC1-HL100809, 1RC1HL100809-01)
National Human Genome Research Institute (R01HG005975, R01HG004906)
National Institute of Diabetes and Digestive and Kidney Diseases (P30DK034933)
National Center for Research Resources (UL1RR024986)
Topics: Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
Keywords: cystic fibrosis, pulmonary exacerbations, airway microbiome, bacterial community diversity, community composition, Pseudomonas, Gemella, biomarkers, lung function decline
MeSH terms: Adolescent, Adult, Child, Cystic Fibrosis, Female, Humans, Lung, Male, Middle Aged, Sputum, Disease Progression, Young Adult, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Changes in Cystic Fibrosis Airway Microbiota at Pulmonary Exacerbation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks